Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron Corp. (OTCMKTS:OMRNY) saw a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 27,640 shares, a growth of 116.6% from the February 12th total of 12,759 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 63,509 shares, the short-interest ratio is presently 0.4 days. Based on an average daily trading volume, of 63,509 shares, the short-interest ratio is presently 0.4 days. Currently, 0.0% of the shares of the stock are short sold.

Institutional Trading of Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC boosted its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,129 shares of the company’s stock after buying an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. 1.09% of the stock is currently owned by hedge funds and other institutional investors.

Omron Stock Performance

Shares of OTCMKTS OMRNY traded down $0.53 during midday trading on Friday, reaching $28.53. 2,901 shares of the stock were exchanged, compared to its average volume of 44,933. The firm has a market cap of $5.88 billion, a price-to-earnings ratio of 36.11, a PEG ratio of 0.46 and a beta of 0.92. The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. The firm has a 50-day simple moving average of $28.72 and a two-hundred day simple moving average of $27.36. Omron has a twelve month low of $23.23 and a twelve month high of $35.90.

Omron (OTCMKTS:OMRNY) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). Omron had a net margin of 2.80% and a return on equity of 2.46%. The business had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, analysts anticipate that Omron will post 0.42 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.